多西·霍奇金2023年讲座:肠内分泌系统-你的肠道中的传感器
1Department of Clinical Biochemistry, Institute of Metabolic Science & MRC Metabolic Diseases Unit, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK.
概括
用于2型糖尿病和肥胖症的葡萄糖类-1 (GLP-1) 药物可以通过在肠道激素细胞中招募储备容量来增强. 准受体或增加营养物质的输送到阴茎可以刺激治疗性激素的释放.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 代谢疾病 代谢疾病
背景情况:
- 基于葡萄糖类-1 (GLP-1) 的药物是2型糖尿病和肥胖症的标准治疗方法.
- GLP-1是一种肠道激素,在饭后由肠内分泌细胞释放出来.
- 肠内分泌细胞拥有用于激素生产的余能力,可以用于治疗.
研究的目的:
- 审查在GLP-1和其他肠道激素表达细胞中招募剩余能力的治疗潜力.
- 探索刺激肠道激素释放的策略,以治疗代谢性疾病.
主要方法:
- 审查关于肠内分泌细胞受体和激素释放机制的现有研究.
- 分析GLP-1和YY (PYY) 表达细胞在阴茎中的分布.
- 讨论针对肠道激素信号的治疗方法.
主要成果:
- 虽然选择性GLP-1增强剂不太可能,但准受体可能会释放有益的肠道激素混合物.
- 结合GLP-1受体激活与其他肠道激素受体的新体显示出有希望的结果.
- 皮质细胞向大肠部的递送增加可能会利用GLP-1和PYY细胞的更高密度.
结论:
- 有很大的潜力来治疗性地招募肠内分泌细胞的剩余容量.
- 通过受体调节或改变营养递送来准肠道激素释放,为2型糖尿病和肥胖提供了新的治疗途径.
关键词:
糖尿病 糖尿病患者 糖尿病患者进入内分泌的内分泌.类似于葡萄糖的-1这是一种依赖葡萄糖的胰岛素型多.肠道激素是一种肠道激素.肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖 肥胖类YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY相关概念视频
Physiology of Enteric Nervous System and Gut Health
307
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
307
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Regulation of the Digestive System
672
Digestive activity regulation hinges on three primary components. Activation is prompted by a multitude of mechanical and chemical indicators, primarily detected by receptors within the stomach and intestines' walls. These receptors predominantly respond to factors such as mechanical stretching of the organ walls, changes in pH and osmolarity, and the presence of digesting materials and their by-products.
The effectors in this regulation system are glands and smooth muscles. Activation of...
The effectors in this regulation system are glands and smooth muscles. Activation of...
672
Physiology of the Gastrointestinal System II: Digestion and Absorption
619
The gastrointestinal (GI) tract, extending from the mouth to the anus, plays a pivotal role in the digestion and absorption of nutrients. This process involves both mechanical and chemical actions facilitated by various enzymes.
Digestion begins in the mouth, where food undergoes mechanical breakdown by chewing and combines with saliva. Salivary amylase, an enzyme in saliva, starts the breakdown of starches into maltose. The food then travels down the esophagus to the stomach.
In the stomach, a...
Digestion begins in the mouth, where food undergoes mechanical breakdown by chewing and combines with saliva. Salivary amylase, an enzyme in saliva, starts the breakdown of starches into maltose. The food then travels down the esophagus to the stomach.
In the stomach, a...
619
Enteric Nervous System: Regulation of GI Motor Activity
451
The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
451
Gastrointestinal Motility Disorders
433
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
433


